InspireMD (NSPR) Stock Price
InspireMD Price
Over the last 17 years InspireMD grew revenue by 5.9% annually, reaching 8.98 M USD. For InspireMD, the net margin of -543.3% is down versus -331.9% a few years ago.
InspireMD stock price
InspireMD business model & stock analysis
Frequently asked questions about InspireMD
9 analysts currently rate the InspireMD stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect InspireMD to generate revenue of 9.80 M USD and earnings per share of -0.35 USD.
Converted at the current exchange rate, the InspireMD share trades at 0.53 EUR (0.60 USD).
The InspireMD share (NSPR) is listed on 2 stock exchanges, including: NASDAQ (NSPR).
The expected revenue of InspireMD is 9.80 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of InspireMD is -25.72 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of InspireMD is currently -1.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the InspireMD stock.
The price-to-sales ratio (P/S) of InspireMD is currently 4.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the InspireMD stock.
The Eulerpool Quality Score for InspireMD is 4/10.
The ISIN of InspireMD is US45779A8466. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of InspireMD is A2PGJ7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of InspireMD is NSPR. The ticker symbol is used to trade InspireMD shares on the stock exchange.
InspireMD stock
InspireMD Peer Group
InspireMD Ticker
All fundamentals and in-depth analysis of InspireMD
Our stock analysis for InspireMD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InspireMD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.